Reducing Wasteful Spending on Discarded Lecanemab in the US Medicare Program.
作者信息
Zhou Frank F, Tseng Chi-Hong, Leng Mei, Delarmente Benjo A, Damberg Cheryl L, Sarkisian Catherine A, Mafi John N
机构信息
Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, California.
RAND Health, RAND, Santa Monica, California.
出版信息
JAMA Intern Med. 2024 Dec 1;184(12):1477-1479. doi: 10.1001/jamainternmed.2024.5292.
Abstract
摘要
相似文献
1
Reducing Wasteful Spending on Discarded Lecanemab in the US Medicare Program.减少美国医疗保险计划中在废弃的莱卡奈单抗上的浪费性支出。
JAMA Intern Med. 2024 Dec 1;184(12):1477-1479. doi: 10.1001/jamainternmed.2024.5292.
2
Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program.美国医疗保险计划中lecanemab及其辅助费用的年度支出估计。
JAMA Intern Med. 2023 Aug 1;183(8):885-889. doi: 10.1001/jamainternmed.2023.1749.
3
Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018.2014 - 2018年美国医疗保险按服务收费计划中低价值医疗服务使用及支出趋势
JAMA Netw Open. 2021 Feb 1;4(2):e2037328. doi: 10.1001/jamanetworkopen.2020.37328.
4
Vaccine wastage in Ghana, Mozambique, and Pakistan: An assessment of wastage rates for four vaccines and the context, causes, drivers, and knowledge, attitudes and practices for vaccine wastage.加纳、莫桑比克和巴基斯坦的疫苗浪费：对四种疫苗的浪费率以及疫苗浪费的背景、原因、驱动因素以及知识、态度和实践的评估。
Vaccine. 2023 Jun 23;41(28):4158-4169. doi: 10.1016/j.vaccine.2023.05.033. Epub 2023 Jun 1.
5
Optimal vial sizes for infliximab injection: a simulation study of Japanese demographic data.优化英夫利昔单抗注射用小瓶规格：基于日本人口统计学数据的模拟研究。
Int J Pharm Pract. 2021 Aug 11;29(4):344-349. doi: 10.1093/ijpp/riab017.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease.Lecanemab：一种用于治疗早期阿尔茨海默病的人源化单克隆抗体。
Ann Pharmacother. 2024 Oct;58(10):1045-1053. doi: 10.1177/10600280231218253. Epub 2023 Dec 14.
8
Reducing Drug Wastage in Pharmaceuticals Dosed by Weight or Body Surface Areas by Optimising Vial Sizes.通过优化药瓶大小来减少按重量或体表面积给药的药品浪费。
Appl Health Econ Health Policy. 2019 Jun;17(3):391-397. doi: 10.1007/s40258-018-0444-0.
9
Lecanemab: Looking Before We Leap.仑卡奈单抗：三思而后行。
Neurology. 2023 Oct 10;101(15):661-665. doi: 10.1212/WNL.0000000000207505. Epub 2023 Jul 21.
10
Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India.儿童癌症护理中化疗药物浪费及造成的经济损失量化：印度一家三级护理公立医院的横断面研究
Cureus. 2024 Jan 11;16(1):e52076. doi: 10.7759/cureus.52076. eCollection 2024 Jan.
引用本文的文献
1
Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries.美国医疗保险受益人中早期使用lecanemab的差异。
JAMA Netw Open. 2025 May 1;8(5):e2511711. doi: 10.1001/jamanetworkopen.2025.11711.
2
Lecanemab for mild Alzheimer disease - is there a way forward?用于轻度阿尔茨海默病的lecanemab——有前进的道路吗？
Drugs Context. 2025 Mar 3;14. doi: 10.7573/dic.2024-12-2. eCollection 2025.
3
Higher than expected telemedicine use by racial and ethnic minority and cognitively impaired Medicare beneficiaries.种族和少数民族以及认知障碍的医疗保险受益人的远程医疗使用高于预期。
Health Aff Sch. 2025 Jan 29;3(1):qxae175. doi: 10.1093/haschl/qxae175. eCollection 2025 Jan.
本文引用的文献
1
Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program.美国医疗保险计划中lecanemab及其辅助费用的年度支出估计。
JAMA Intern Med. 2023 Aug 1;183(8):885-889. doi: 10.1001/jamainternmed.2023.1749.
2
Trends in Medicare Part B Spending on Discarded Drugs, 2017-2020.2017 - 2020年医疗保险B部分在废弃药物上的支出趋势
JAMA Intern Med. 2023 Feb 1;183(2):164-167. doi: 10.1001/jamainternmed.2022.5890.
3
Estimated wasteful spending on aducanumab dispensing in the U.S. Medicare population: A cross-sectional analysis.美国医疗保险人群中阿杜卡单抗配药的估计浪费性支出：一项横断面分析。
J Am Geriatr Soc. 2022 Sep;70(9):2714-2718. doi: 10.1111/jgs.17891. Epub 2022 Jun 27.
4
Overspending driven by oversized single dose vials of cancer drugs.超大剂量单剂量瓶癌症药物导致的超支。
BMJ. 2016 Feb 29;352:i788. doi: 10.1136/bmj.i788.
Zotero 插件